Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02043691 · ClinicalTrials.gov registry record · NA

Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies

A NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
410
Enrollment target
1
Study location

NCT02043691 is a NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 410 participants, below the 627-participant average among 11 other Aortic Dissection trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02043691, a NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
410 participants
Enrollment target
1
Study location

Study Summary

This is a single-center study to evaluate the safety and effectiveness of three investigational devices, the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endografts in the treatment of Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch pathologies involving the at least one brachiocephalic artery or visceral vessels. The three investigational devices offer an endovascular approach to treat complex aortic pathologies that cannot be treated with commercially available devices. This customized, endovascular approach has the potential to decrease hospital length of stay, pulmonary complications, and in-hospital mortality.

Interventions

  • DEVICE Cook Custom Aortic Endograft
  • DEVICE Zenith t-Branch Endovascular Graft
  • DEVICE Surgeon-Modified Endograft

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2014-06
Est. Completion 2027-10
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02043691

The ClinicalTrials.gov registry entry for NCT02043691 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 627-participant average among 11 other Aortic Dissection trials with a reported enrollment target (35% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Aortic Dissection appearing as the primary indexed condition, and to 3 interventions - of which Cook Custom Aortic Endograft is the first listed.

NCT02043691 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02043691 about?

NCT02043691 is a clinical study titled "Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies". This is a single-center study to evaluate the safety and effectiveness of three investigational devices, the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endografts in the treatment of Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch patholo...

What is the current status of trial NCT02043691?

This trial is currently recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2014-06. Estimated completion is 2027-10.

What conditions does trial NCT02043691 study?

This clinical trial studies the following conditions: Aortic Dissection, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Juxtarenal Aortic Aneurysm, Penetrating Aortic Ulcer.

What interventions are being tested in trial NCT02043691?

The interventions under investigation include: Cook Custom Aortic Endograft (DEVICE), Zenith t-Branch Endovascular Graft (DEVICE), Surgeon-Modified Endograft (DEVICE).

Who is sponsoring clinical trial NCT02043691?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02043691 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.